Paula Guijarro-Sánchez

发表

Reply to Shapiro, “Cefepime/Enmetazobactam Is a Clinically Effective Combination Targeting Extended-Spectrum β-Lactamase-Producing Enterobacterales”

G. Bou, A. Beceiro, M. Oviaño, 2022, Antimicrobial agents and chemotherapy.

Activity of Imipenem, Meropenem, Cefepime, and Sulbactam in Combination with the β-Lactamase Inhibitor LN-1-255 against Acinetobacter spp.

C. González‐Bello, G. Bou, J. Buynak, 2021, Antibiotics.

Activity of cefiderocol, imipenem/relebactam, cefepime/taniborbactam and cefepime/zidebactam against ceftolozane/tazobactam- and ceftazidime/avibactam-resistant Pseudomonas aeruginosa.

A. Oliver, G. Bou, A. Beceiro, 2022, The Journal of antimicrobial chemotherapy.

Carbapenem Resistance in Acinetobacter nosocomialis and Acinetobacter junii Conferred by Acquisition of blaOXA-24/40 and Genetic Characterization of the Transmission Mechanism between Acinetobacter Genomic Species

C. Fernandez-Lozano, G. Bou, A. Beceiro, 2022, Microbiology spectrum.

Selection of AmpC β-Lactamase Variants and Metallo-β-Lactamases Leading to Ceftolozane/Tazobactam and Ceftazidime/Avibactam Resistance during Treatment of MDR/XDR Pseudomonas aeruginosa Infections

A. Oliver, C. González‐Bello, G. Bou, 2021, Antimicrobial agents and chemotherapy.

Assessment of Activity and Resistance Mechanisms to Cefepime in Combination with the Novel β-Lactamase Inhibitors Zidebactam, Taniborbactam, and Enmetazobactam against a Multicenter Collection of Carbapenemase-Producing Enterobacterales

G. Bou, A. Beceiro, M. Oviaño, 2021, Antimicrobial agents and chemotherapy.

Emergence of 16S rRNA methyltransferases among carbapenemase-producing Enterobacterales in Spain studied by WGS.

T. Alioto, M. Gut, I. Gut, 2021, International journal of antimicrobial agents.

Occurrence of the p019 Gene in the blaKPC-Harboring Plasmids: Adverse Clinical Impact for Direct Tracking of KPC-Producing Klebsiella pneumoniae by Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry

T. Alioto, M. Gut, I. Gut, 2021, Journal of clinical microbiology.

Antimicrobial Activity of Cefiderocol against the Carbapenemase-Producing Enterobacter cloacae Complex and Characterization of Reduced Susceptibility Associated with Metallo-β-Lactamase VIM-1

C. González‐Bello, G. Bou, A. Beceiro, 2023, Antimicrobial agents and chemotherapy.

Simultaneous and divergent evolution of resistance to cephalosporin/β-lactamase inhibitor combinations and imipenem/relebactam following ceftazidime/avibactam treatment of MDR Pseudomonas aeruginosa infections.

A. Oliver, G. Bou, A. Beceiro, 2023, Journal of Antimicrobial Chemotherapy.

Interplay between OXA-10 β-Lactamase Production and Low Outer-Membrane Permeability in Carbapenem Resistance in Enterobacterales

C. González‐Bello, G. Bou, A. Beceiro, 2023, Antibiotics.

In vitro development of imipenem/relebactam resistance in KPC-producing Klebsiella pneumoniae involves multiple mutations including OmpK36 disruption and KPC modification.

C. González‐Bello, G. Bou, L. Martínez-Martínez, 2023, International journal of antimicrobial agents.